Down syndrome families' fight for access to Alzheimer's trials, treatments
Down syndrome affects 400,000 people in the United States and more than 6 million globally.
Sun Oct 29 2023
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
The proposed guidelines, embrace a numerical staging system assessing disease progression similar to the one used in cancer diagnoses.
Sat Jul 29 2023
Experimental drug works best for Alzheimer's patients treated as early as possible
The drug, donanemab, has been shown to slow progression of memory and thinking problems by about a third.
Tue Jul 18 2023
'Remarkable' Alzheimer drug reduces cognitive decline, results show
Eli Lilly announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline.
Fri May 05 2023